OLFML3 negatively regulates RIG-I signaling in RNA virus infection

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Olfactomedin-like protein 3 (OLFML3) is a secreted glycoprotein involved in development and tumorigenesis.
• Emerging evidence implicates OLFML3 in regulating responses to viral and bacterial infections.
• This study investigates OLFML3's role in type I interferon (IFN-I) signaling during RNA virus infections.

Purpose of the Study:

• To elucidate the mechanism by which OLFML3 influences IFN-I signaling in the context of RNA virus infection.
• To identify OLFML3's interacting partners within the IFN-I signaling pathway.
• To explore the potential of targeting OLFML3 for antiviral therapeutic strategies.

Main Methods:

• Quantitative reverse transcription PCR (RT-qPCR) to assess IFN-I production.
• Olfml3 knockout mice for in vivo infection models.
• Western blotting and immunofluorescence microscopy to analyze the RIG-I signaling pathway.
• Mass spectrometry and co-immunoprecipitation (Co-IP) for protein interaction analysis.
• Gain-of-function and loss-of-function studies for OLFML3 and TRIM21.

Main Results:

• OLFML3 inhibits IFN-I production by suppressing RIG-I signaling in RNA virus infections.
• OLFML3 directly interacts with TRIM21, an E3 ubiquitin ligase, via its PRY/SPRY domain.
• OLFML3 disrupts TRIM21-mediated K63-ubiquitination of RIG-I, leading to RIG-I destabilization and suppressed IFN-I signaling.

Conclusions:

• OLFML3 acts as a general immunosuppressor in RNA virus infections by inhibiting the RIG-I signaling pathway.
• Understanding OLFML3's function provides insights into viral immune evasion mechanisms.
• Targeting OLFML3 may offer a novel therapeutic approach to reactivate IFN-I signaling and combat viral infections.